MG
Therapeutic Areas
GT Metabolic Solutions Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MagDI™ System | Side-to-side duodeno-ileal anastomosis for weight loss and glycemic control in severe obesity with/without type 2 diabetes | Approved |
| Drug | Indication | Phase |
|---|---|---|
| MagDI™ System | Side-to-side duodeno-ileal anastomosis for weight loss and glycemic control in severe obesity with/without type 2 diabetes | Approved |